menu
    • menu

    Company profile for Nymox Pharmaceutical

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nymox Pharmaceutical Corporation specializes in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the rapidly aging male population in developed economies. The Company’s lead drug candidate for benign prostatic hyperplasia (BPH) Fexapotide Triflutate (FT) has completed Phase 3 development in more than 70 clinical centers in the United States, ...
    Nymox Pharmaceutical Corporation specializes in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the rapidly aging male population in developed economies. The Company’s lead drug candidate for benign prostatic hyperplasia (BPH) Fexapotide Triflutate (FT) has completed Phase 3 development in more than 70 clinical centers in the United States, involving more than 1700 patients during the entire clinical development program. Currently, the Company will soon be filing for approval in major economies around the world, including the United States and Europe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nymox PharmaceuticalCanada Flag
    Country
    Country
    Canada
    Address
    Address
    9900 Cavendish Boulevard St.-Laurent, Quebec
    Telephone
    Telephone
    (800) 936-9669
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nymox.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nymox Announces Dismissal of Delaware Action Against Ascella
    Nymox Announces Dismissal of Delaware Action Against Ascella

    11 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/11/3040930/0/en/Nymox-Announces-Dismissal-of-Delaware-Action-Against-Ascella.html

    GLOBENEWSWIRE
    11 Mar 2025
    Share Share
    Nymox Announces Trading Resumed and New Listing on OTCQB Market
    Nymox Announces Trading Resumed and New Listing on OTCQB Market

    17 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/17/2998370/0/en/NYMOX-Announces-Trading-Resumed-and-New-Listing-on-OTCQB-Market.html

    GLOBENEWSWIRE
    17 Dec 2024
    Share Share
    Nymox Announces Filing of Annual Report
    Nymox Announces Filing of Annual Report

    30 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/30/2938560/10918/en/Nymox-Announces-Filing-of-Annual-Report.html

    GLOBENEWSWIRE
    30 Aug 2024
    Share Share
    Nymox Annual Report
    Nymox Annual Report

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915548/10918/en/Nymox-Annual-Report.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    Nymox Required to Resubmit Application to DKMA
    Nymox Required to Resubmit Application to DKMA

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913880/10918/en/Nymox-Required-to-Resubmit-Application-to-DKMA.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees
    Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees

    27 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/27/2853282/10918/en/Nymox-Reports-Victory-in-Bahamas-Litigation-Against-Terminated-Ex-Employees-Court-Awards-Costs-and-Damages.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search